Thyroid function tests

Thyroid function tests
Intervention
MeSH D013960
MedlinePlus 003444

Thyroid function tests (TFTs) is a collective term for blood tests used to check the function of the thyroid.[1]

TFTs may be requested if a patient is thought to suffer from hyperthyroidism (overactive thyroid) or hypothyroidism (underactive thyroid), or to monitor the effectiveness of either thyroid-suppression or hormone replacement therapy. It is also requested routinely in conditions linked to thyroid disease, such as atrial fibrillation and anxiety disorder.

A TFT panel typically includes thyroid hormones such as thyroid-stimulating hormone (TSH, thyrotropin) and thyroxine (T4), and triiodothyronine (T3) depending on local laboratory policy.

Thyroid hormones

Thyroid-stimulating hormone

Thyroid-stimulating hormone (TSH, thyrotropin) is generally elevated in hypothyroidism and decreased in hyperthyroidism.[2]

It is the most sensitive test for thyroid hormone function. TSH is produced in the pituitary gland. The production of TSH is controlled by TRH, which is produced in the hypothalamus. TSH levels may be suppressed by excess free T3 or free T4 in the blood.

Total thyroxine

Total thyroxine is rarely measured, having been largely superseded by free thyroxine tests. Total thyroxine (Total T4) is generally elevated in hyperthyroidism and decreased in hypothyroidism.[2] It is usually slightly elevated in pregnancy secondary to increased levels of thyroid binding globulin (TBG).[2]

Total T4 is measured to see the bound and unbound levels of T4. The total T4 is less useful in cases where there could be protein abnormalities. The total T4 is less accurate due to the large amount of T4 that is bound. The total T3 is measured in clinical practice since the T3 has decreased amount that is bound as compared to T4.

Reference ranges depend on the method of analysis. Results should always be interpreted using the range from the laboratory that performed the test. Example values are:

Lower limitUpper limitUnit
4,[3] 5.5[4] 11,[3] 12.3[4] μg/dL
60[3][5] 140,[3] 160[5] nmol/L

Free thyroxine

Free thyroxine (Free T4) is generally elevated in hyperthyroidism and decreased in hypothyroidism.[2]

Reference ranges depend on the method of analysis. Results should always be interpreted using the range from the laboratory that performed the test. Example values are:

Patient typeLower limitUpper limitUnit
Normal adult 0.7,[6] 0.8[4] 1.4,[6] 1.5,[4] 1.8[7] ng/dL
9,[8][9] 10,[3] 12 [5] 18,[8][9] 23[5] pmol/L
Infant 0–3 d 2.0[6] 5.0[6] ng/dL
26[9] 65[9] pmol/L
Infant 3–30 d 0.9[6] 2.2[6] ng/dL
12[9] 30[9] pmol/L
Child/Adolescent
31 d – 18 y
0.8[6] 2.0[6] ng/dL
10[9] 26[9] pmol/L
Pregnant 0.5[6] 1.0[6] ng/dL
6.5[9] 13[9] pmol/L

Total triiodothyronine

Total triiodothyronine (Total T3) is rarely measured, having been largely superseded by free T3 tests. Total T3 is generally elevated in hyperthyroidism and decreased in hypothyroidism.[2]

Reference ranges depend on the method of analysis. Results should always be interpreted using the range from the laboratory that performed the test. Example values are:

TestLower limitUpper limitUnit
Total triiodothyronine 60,[4] 75[3] 175,[3] 181[4] ng/dL
0.9,[8] 1.1[3] 2.5,[8] 2.7[3] nmol/L

Free triiodothyronine

Free triiodothyronine (Free T3) is generally elevated in hyperthyroidism and decreased in hypothyroidism.[2]

Reference ranges depend on the method of analysis. Results should always be interpreted using the range from the laboratory that performed the test. Example values are:

Patient typeLower limitUpper limitUnit
Normal adult 3.0[3] 7.0[3] pg/mL
3.1[10] 7.7[10] pmol/L
Children 2–16 y 3.0[11] 7.0[11] pg/mL
1.5[10] 15.2[10] pmol/L

Carrier proteins

Thyroxine-binding globulin

An increased thyroxine-binding globulin results in an increased total thyroxine and total triiodothyronine without an actual increase in hormonal activity of thyroid hormones.

Reference ranges:

Lower limitUpper limitUnit
12[4] 30[4] mg/L

Thyroglobulin

Reference ranges:

Lower limitUpper limitUnit
1.5[3] 30[3] pmol/L
1[3] 20 [3] μg/L

Other binding hormones

Protein binding function

Thyroid hormone uptake

Thyroid hormone uptake (Tuptake or T3 uptake) is a measure of the unbound thyroxine binding globulins in the blood, that is, the TBG that is unsaturated with thyroid hormone.[2] Unsaturated TBG increases with decreased levels of thyroid hormones. It is not directly related to triiodothyronine, despite the name T3 uptake.[2]

Reference ranges:

Patient typeLower limitUpper limitUnit
Females 25[2] 35[2] %
In pregnancy 15[2] 25[2] %
Males 25[2] 35[2] %

Other protein binding tests

Mixed parameters

Free thyroxine index

The Free Thyroxine Index (FTI or T7) is obtained by multiplying the total T4 with Tuptake.[2] FTI is considered to be a more reliable indicator of thyroid status in the presence of abnormalities in plasma protein binding.[2] This test is rarely used now that reliable free thyroxine and free triiodothyronine assays are routinely available.

FTI is elevated in hyperthyroidism and decreased in hypothyroidism.[2]

Patient typeLower limitUpper limitUnit
Females 1.8[2] 5.0[2]
Males 1.3[2] 4.2[2]

Structure parameters

For special purposes, e.g. in diagnosis of nonthyroidal illness syndrome or central hypothyroidism, derived structure parameters that describe constant properties of the overall feedback control system, may add useful information.[12][13][14]

Secretory capacity (GT)

Thyroid's secretory capacity (GT, also referred to as SPINA-GT) is the maximum stimulated amount of thyroxine the thyroid can produce in one second.[15] GT is elevated in hyperthyroidism and reduced in hypothyroidism.[16]

GT is calculated with

\hat G_T  = {{\beta _T (D_T  + [TSH])(1 + K_{41} [TBG] + K_{42} [TBPA])[FT_4 ]} \over {\alpha _T [TSH]}}

or

\hat G_T  = {{\beta _T (D_T  + [TSH])[TT_4 ]} \over {\alpha _T [TSH]}}

\alpha _T: Dilution factor for T4 (reciprocal of apparent volume of distribution, 0.1 l−1)
\beta _T: Clearance exponent for T4 (1.1e-6 sec−1)
K41: Dissociation constant T4-TBG (2e10 l/mol)
K42: Dissociation constant T4-TBPA (2e8 l/mol)
DT: EC50 for TSH (2.75 mU/l)[15]

Lower limitUpper limitUnit
1.41[15] 8.67[15] pmol/s

Sum activity of peripheral deiodinases (GD)

The sum activity of peripheral deiodinases (GD, also referred to as SPINA-GD) is reduced in nonthyroidal illness with hypodeiodination.[13][14]

GD is obtained with

\hat G_D  = {{\beta _{31} (K_{M1}  + [FT_4 ])(1 + K_{30} [TBG])[FT_3 ]} \over {\alpha _{31} [FT_4 ]}}

or

\hat G_D  = {{\beta _{31} (K_{M1}  + [FT_4 ])[TT_3 ]} \over {\alpha _{31} [FT_4 ]}}

\alpha _{31}: Dilution factor for T3 (reciprocal of apparent volume of distribution, 0.026 l−1)
\beta _{31}: Clearance exponent for T3 (8e-6 sec−1)
KM1: Dissociation constant of type-1-deiodinase (5e-7 mol/l)
K30: Dissociation constant T3-TBG (2e9 l/mol)[15]

Lower limitUpper limitUnit
20[15] 40[15] nmol/s

TSH index

Jostel's TSH index (TSHI) helps to determine thyrotropic function of anterior pituitary on a quantitative level.[17]

It is calculated with

TSHI = LN(TSH) + 0.1345 * FT4.

Additionally, a standardized form of TSH index may be calculated with

sTSHI = (TSHI - 2.7)/0.676.[17]

ParameterLower limitUpper limitUnit
TSHI 1.3[17] 4.1[17]
sTSHI -2[17] 2[17]

TTSI

The Thyrotroph Thyroid Hormone Sensitivity Index (TTSI, also referred to as Thyrotroph T4 Resistance Index or TT4RI) was developed to enable fast screening for resistance to thyroid hormone.[18][19] Somewhat similar to the TSH Index it is calculated from equilibrium values for TSH and FT4, however with a different equation.

Lower limitUpper limitUnit
100 150

See also

Reference ranges for blood tests, sorted by mass and molar concentration, with thyroid function tests marked in purple boxes in left half of diagram.

References

  1. Dayan CM (February 2001). "Interpretation of thyroid function tests". Lancet 357 (9256): 619–24. doi:10.1016/S0140-6736(00)04060-5. PMID 11558500.
  2. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Military Obstetrics & Gynecology > Thyroid Function Tests In turn citing: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Table 4: Typical reference ranges for serum assays - Thyroid Disease Manager
  4. 1 2 3 4 5 6 7 8 Normal Reference Range Table from The University of Texas Southwestern Medical Center at Dallas. Used in Interactive Case Study Companion to Pathologic basis of disease.
  5. 1 2 3 4 van der Watt G, Haarburger D, Berman P (July 2008). "Euthyroid patient with elevated serum free thyroxine". Clin. Chem. 54 (7): 1239–41. doi:10.1373/clinchem.2007.101428. PMID 18593963.
  6. 1 2 3 4 5 6 7 8 9 10 Free T4; Thyroxine, Free; T4, Free UNC Health Care System
  7. Derived from molar values using molar mass of 776.87 g/mol
  8. 1 2 3 4 Reference range list from Uppsala University Hospital ("Laborationslista"). Artnr 40284 Sj74a. Issued on April 22, 2008
  9. 1 2 3 4 5 6 7 8 9 10 Derived from mass values using molar mass of 776.87 g/mol
  10. 1 2 3 4 Derived from mass values using molar mass of 650.98 g/mol
  11. 1 2 Cioffi M, Gazzerro P, Vietri MT, et al. (2001). "Serum concentration of free T3, free T4 and TSH in healthy children". J. Pediatr. Endocrinol. Metab. 14 (9): 1635–9. doi:10.1515/JPEM.2001.14.9.1635. PMID 11795654.
  12. Dietrich, J. W., A. Stachon, B. Antic, H. H. Klein, and S. Hering (2008). "The AQUA-FONTIS Study: Protocol of a multidisciplinary, cross-sectional and prospective longitudinal study for developing standardized diagnostics and classification of non-thyroidal illness syndrome." BMC Endocrine Disorders 8 (13). PMID 18851740.
  13. 1 2 Rosolowska-Huszcz D, Kozlowska L, Rydzewski A (August 2005). "Influence of low protein diet on nonthyroidal illness syndrome in chronic renal failure". Endocrine 27 (3): 283–8. doi:10.1385/ENDO:27:3:283. PMID 16230785.
  14. 1 2 Liu S, Ren J, Zhao Y, Han G, Hong Z, Yan D, Chen J, Gu G, Wang G, Wang X, Fan C, Li J (2012). "Nonthyroidal Illness Syndrome: Is it Far Away From Crohn's Disease?". J Clin Gastroenterol. 47 (2): 153–9. doi:10.1097/MCG.0b013e318254ea8a. PMID 22874844.
  15. 1 2 3 4 5 6 7 Dietrich, J. W. (2002). Der Hypophysen-Schilddrüsen-Regelkreis. Berlin, Germany: Logos-Verlag Berlin. ISBN 978-3-89722-850-4. OCLC 50451543. 3897228505
  16. Dietrich, J., M. Fischer, J. Jauch, E. Pantke, R. Gärtner und C. R. Pickardt (1999). "SPINA-THYR: A Novel Systems Theoretic Approach to Determine the Secretion Capacity of the Thyroid Gland." European Journal of Internal Medicine 10, Suppl. 1 (5/1999): S34.
  17. 1 2 3 4 5 6 Jostel A, Ryder WD, Shalet SM (October 2009). "The use of thyroid function tests in the diagnosis of hypopituitarism: definition and evaluation of the TSH Index". Clin. Endocrinol. (Oxf) 71 (4): 529–34. doi:10.1111/j.1365-2265.2009.03534.x. PMID 19226261.
  18. Yagi H, Pohlenz J, Hayashi Y, Sakurai A, Refetoff S. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3'-triiodothyroinine binding affinity. J Clin Endocrinol Metab. 1997 May;82(5):1608-14. PMID 9141558
  19. Pohlenz J, Weiss RE, Macchia PE, Pannain S, Lau T, Ho H, Refetoff S. Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene. J Clin Endocrinol Metab. 1999 Nov;84(11):3919-28. PMID 10566629

Further reading

External links

This article is issued from Wikipedia - version of the Sunday, February 14, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.